From UNGA to Yokohama: ICPC and ICGC ARGO unite global stakeholders to deliver precision oncology to patients
Yokohama, Japan: On Wednesday, 1 October 2025 (15:30–17:30 JST), the International Cancer Patient Coalition (ICPC) and ICGC ARGO will convene a high-level forum at Pacifico Yokohama North (Room G314+G315): From Pipeline to Patient: Delivering on the Promise of Precision Oncology and Beyond.
Building on the momentum from United Nations High-Level Week in New York and the Last Mile Action Agenda (equitable early detection; partnerships and capacity; sustainable financing), the Yokohama forum focuses on translating political commitment into practical delivery in clinics and cancer centres. More than 200 policy makers and stakeholders participated around UNGA; a similar number is expected to engage in Yokohama. This forum also builds on the Vision Europe conference in Brussels, where the European Alliance for Personalised Medicine convened regional leaders to align on European priorities for precision oncology delivery and equitable access.
Why this matters: Breakthroughs in genomics, biomarkers, AI, and innovative trial designs only change lives when they reach the bedside. This forum brings clinicians, scientists, policymakers, industry, and patient advocates into one room to agree concrete steps countries can adopt and scale.
Programme highlights (JST)
- 15:30–15:45 — Welcome and context
- 15:45–16:10 — Debate 1: Is genomics reaching the patient bedside?
- 16:10–16:40 — Debate 2: Stratified screening as the new frontline
- 16:40–17:10 — Debate 3: Trials and real-world data — a genomic inclusion test
- 17:10–17:30 — Closing and next steps
What attendees will gain
- Early detection ready to implement: risk-stratified screening models with measurable targets for stage shift and time to result
- Capacity and partnerships that last: interoperable data standards, workforce upskilling, connected centres with patient navigation built in
- Financing that enables access: clear routes to reimburse essential diagnostics and biomarkers, and the use of real-world evidence to support responsible adoption
How to engage
- Attend in person on 1 October, 15:30–17:30 JST, Pacifico Yokohama North
- Schedule bilateral meetings on country delivery, partnerships, or pilot implementation
- Share outcomes with your networks and align national plans to the Last Mile priorities
- Media and policy briefings available on request
About the event
- From Pipeline to Patient: Delivering on the Promise of Precision Oncology and Beyond
- Date/Time: Wednesday, 1 October 2025 | 15:30–17:30 JST
- Venue: Pacifico Yokohama North, Room G314+G315
About ICGC ARGO: ICGC ARGO is a collaborative international programme advancing genomic oncology by standardising data, catalysing discovery, and enabling real-world impact for patients.
About ICPC: The International Cancer Patient Coalition (ICPC) is a global, patient-led organisation that bridges patients and policymakers to translate commitments into equitable access, accelerating earlier detection, smarter treatment, and fair coverage across regions.
Media and RSVP contact:
Chiara de Tomasso
Ph: + 39 388 371 7597
Website: www.euapm.eu
Email: chiara.de.tomasso@euapm.eu